Chris Freeman, Chief Commercial Officer at Guardant Health, Inc. (GH), divested a significant number of shares on August 11, 2026. Freeman sold 35,364 shares of GH stock at an average price of $169.63 per share, resulting in a total transaction value of approximately $6.00 million.
This transaction follows other sales by Freeman earlier in August, where he sold an additional 63,475 shares across multiple transactions, totaling over $10.7 million. Additionally, Manuel Hidalgo Medina, another executive at the company, sold shares on August 5, 2026.
Insider selling activity can be attributed to various personal financial decisions, such as portfolio diversification or tax planning, and does not necessarily indicate a negative view of the company's future prospects.